Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression

Transplantation

Volumn 66, Issue 11, 1998, Pages 1424-1431

  Saito, Satoshi ^a   Foegh, Marie L ^a   Motomura, Noboru ^a   Lou, Hong ^a   Kent, Kenneth ^b   Ramwell, Peter W ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; ESTRADIOL; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGEN-PRESENTING CELLS; AORTA, ABDOMINAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ESTRADIOL; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; MACROPHAGES; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; RECEPTORS, INTERFERON; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032535665     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812150-00004     Document Type: Article

References (39)

1. Kofnek SD. Postmenopausal hormone replacement therapy and cardiovascular risk reduction. Drugs 1994; 47 (suppl 2): 16.
2. Nabulsi AA, Folsom AR, White A, et al. Association of hormone replacement therapy with various cardiovascular risk factors in post menopausal woman. N Engl J Med 1993; 328: 1069.
3. Lou H, Kodama T, Zhao YJ, et al. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation 1996; 94 (12): 3355.
4. Motomura N, Lou H, Maurice P, Foegh ML. Acceleration of arteriosclerosis of the rat aorta allograft by insulin growth factor-I. Transplantation 1997; 63 (7): 932.
5. Bach EA, Szabo SJ, Dighe AS, et al. Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 1995; 270 (5239): 1215.
6. Arkins S, Rebeitz N, Brunke-Reese DL, Biragym A, Kelley KW. Interferon gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol Endocrinol 1995; 9: 350.
7. Russell ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the LEW to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97 (3): 833.
8. Ezekowitz RA, Gordon S. Alterations of surface property by macrophage activation: expression of receptors for Fc mannose terminal glycoproteins and differential antigen. Contemp Immunobiol 1984; 13: 33.
9. Campos L, Deli BC, Kern JH, Kim JI, Barker CF, Markmann JF. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187.
10. Qian S, Fu F, Lu L, et al. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allograft. Immunology 1996; 88: 124.
11. White E, Hildemann WH, Mullen Y. Chronic kidney allograft reactions in rats. Transplantation 1969; 8 (5): 602.
12. Klempnauer J, Marquarding E. RT1.C and rat bone marrow transplantation. Transplant Proc 1989; 21 (2): 3292.
13. Schmid C, Heemann U, Tilney NL. Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation. Transplantation 1997; 64 (2): 222.
14. Russel PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts: effects of recipient treatment with a monoclonal antibody to interferon-γ. Transplantation 1994; 57: 1367.
15. Clausell N, Molossi S, Sett S, Rabinovitch M. in vivo blockade of tumor necrosis factor alpha in cholesterol fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. Circulation 1994; 89: 2768.
16. Amaildi I, Reith W, Berte C, Mach B. Induction of HLA genes by IFN-γ is transcriptional and requires transacting protein. J Immunol 1989; 142: 999.
17. Pober JS, Collins T, Gimbrone MA Jr, Libby P, Reiss CS. Inducible expression of class II major histocompatibility complex antigens: the immunogenicity of vascular antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 11: 9.
18. Debout C, Lefroit-Joliy M, Neveu TJ, Izard J. 17-β estradiol affects the expression of guinea pig blood leukocytes MhC antigens. J Steroid Biochem Mol Biol 1991; 38: 695.
19. Fox FS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promotor. J Immunol 1991; 146: 4362.
20. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10 (13): 13.
21. Tabibzadeh SS, Sivarajah A, Carpenter D, Wilhelm BM, Satyasvaram PG. Modulation of HLA-DR expression in epithelial cells by interleukin-1 and estradiol-17β. J Clin Endocrinol Metab 1990; 71: 740.
22. Spits H, de Wall Malefyt R. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992; 99: 8.
23. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science 1993; 260: 496.
24. Wu CJ, Lovertt M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 1992; 54: 326.
25. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 17β estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994; 93: 944.
26. Khirabadi BS, Foegh ML, Ramwell PW. Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection. Transplantation 1985; 39: 6.
27. Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifen. Science 1996; 273: 1222.
28. Ratajczak T, Mark PJ, Martin RL, Minchin RF. Cyclosporin A potentiates estradiol-induced expression of the cathepsin D gene in MCF7 breast cancer cells. Biochem Biophys Res Commun 1996; 220: 208.
29. Oparil S, Levine RL, Chen SJ, Durand J, Chen YF. Sexually dimorphic response of the balloon injured rat carotid artery to hormone treatment. Circulation 1997; 95: 1301.
30. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allograft. Transplantation 1991; 52: 967.
31. Foegh ML, Khirabadi DS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant arteriosclerosis. Transplant Proc, 1987; 19 (Suppl 5): 90.
32. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181 (5): 869.
33. Cohn ZA. The activation of mononuclear phagocytes: facts, fancy, and future. J Immunol 1978; 121: 813.
34. Willson SE, Lyoyd SA. Epidermal growth factor and its receptor, basic fibroblast growth factors, transforming growth factor β-1, and interleukin-1α mRNA production in human corneal endothelial cells. Invest Opthalmol Vis Sci 1991; 32: 2747.
35. Auernhammer CJ, Strassberger CJ. Effects of growth hormone and insulin-like growth factor αa I on the immune system. Eur J Endocrinol 1995; 133: 635.
36. Lou H, Zhao Y, Delafontaine P, Kodama T, Katz N, Foegh ML. Estrogen effects on insulin growth factor-I (IGF-I) induced cell proliferation and IGF-I expression in native and allograft vessels. Circulation 1997; 96: 927.
37. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. Effects of 17β-estradiol on cytokine induced endothelial cell adhesion molecule expression. J Clin Invest 1996; 98: 36.
38. Yahata T, Kurabayashi T, Honda A, Tojo Y, Tanaka K, Abo T. Physiological dose of estrogen regulates extrathymic T cells in female mice. Cell Immunol 1996; 171 (2): 269.
39. Deshpande RR, Chapman JC, Michael SD. The anovulation in female mice resulting from postnatal injections of estrogen is correlated with altered levels of CD8+ lymphocytes. Am J Reprod Immunol 1997; 38 (2): 114.